In Other News

• AI Tool Identifies Slide Artifacts to Speed Digital Pathology Diagnosis

• Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis

• Collaboration Supports Global ADC Development with AI-Powered Tissue Analysis

• Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections

• Immune Cell Blood Test May Predict Melanoma Immunotherapy Response

• Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis

• Compact Prenatal Screening System Expands Access to Preeclampsia Testing

• FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

• Newborn Screening Program Adds Spinal Muscular Atrophy Testing Across England

• Immune Cell Blood Test May Predict Melanoma Immunotherapy Response

• Compact Prenatal Screening System Expands Access to Preeclampsia Testing

• Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

• Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

• Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings

• Liquid Biopsy Assay Enriches Tumor DNA for Early Detection and Monitoring

• New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome

• Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection

• FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

• D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer

• Study Reveals Viral Protein Driving COVID-19-Related Vascular Injury

• New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome

• Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

• New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance